Literature DB >> 17207898

Olfaction in patients with mild cognitive impairment and Alzheimer's disease.

Jelena Djordjevic1, Marilyn Jones-Gotman, Kathy De Sousa, Howard Chertkow.   

Abstract

Understanding of olfactory dysfunction in Alzheimer's disease (AD) remains limited. In particular, it is not known how early in the course of the disease olfactory deficits occur, and whether they are restricted to identification or involve other aspects of olfaction. We studied olfactory (odor detection thresholds, quality discrimination, and identification) and cognitive (attention, reasoning, memory, naming and fluency) functioning in patients with AD, with mild cognitive impairment (MCI), and in normal elderly control (NEC) participants. MCI patients were impaired in olfactory sensitivity and identification, while a discrimination deficit was accounted for by abnormal thresholds. AD patients were impaired in all three domains, and were worse than the MCI group. Odor discrimination (OD) and identification performance correlated more prominently than detection thresholds with performance on neuropsychological tests. We concluded that deficits in olfactory detection thresholds and identification occur early in AD, before clinical symptoms are fully developed, and decline further over the course of the disease. High detection thresholds, together with impaired identification, may be useful as an early indicator of AD.

Entities:  

Mesh:

Year:  2007        PMID: 17207898     DOI: 10.1016/j.neurobiolaging.2006.11.014

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  107 in total

1.  Cognitive decline is associated with reduced reelin expression in the entorhinal cortex of aged rats.

Authors:  Alexis M Stranahan; Rebecca P Haberman; Michela Gallagher
Journal:  Cereb Cortex       Date:  2010-06-10       Impact factor: 5.357

2.  Semantic networks for odors and colors in Alzheimer's disease.

Authors:  Jill Razani; Agnes Chan; Steven Nordin; Claire Murphy
Journal:  Neuropsychology       Date:  2010-05       Impact factor: 3.295

3.  Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease.

Authors:  Wen Li; James D Howard; Jay A Gottfried
Journal:  Brain       Date:  2010-08-19       Impact factor: 13.501

4.  Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project.

Authors:  Yuriko Katsumata; Hidemi Todoriki; Yasushi Higashiuesato; Shotoku Yasura; D Craig Willcox; Yusuke Ohya; Bradley J Willcox; Hiroko H Dodge
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-10-20       Impact factor: 6.053

5.  Linking biological and cognitive aging: toward improving characterizations of developmental time.

Authors:  Stuart W S MacDonald; Correne A DeCarlo; Roger A Dixon
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

Review 6.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

7.  Effect of basal forebrain stimulation on extracellular acetylcholine release and blood flow in the olfactory bulb.

Authors:  Sae Uchida; Fusako Kagitani
Journal:  J Physiol Sci       Date:  2017-05-12       Impact factor: 2.781

Review 8.  Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia.

Authors:  Howard Chertkow; Fadi Massoud; Ziad Nasreddine; Sylvie Belleville; Yves Joanette; Christian Bocti; Valérie Drolet; John Kirk; Morris Freedman; Howard Bergman
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

Review 9.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

Review 10.  Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.

Authors:  Coleman B Calva; Jim R Fadel
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.